NANOFORM FINLAND OYJ |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.155 EUR | +6.16% |
|
-15.16% | +35.96% |
| Apr. 11 | Nanoform Finland to Deliver Nanomedicine Technology to Japan | MT |
| Apr. 11 | Nanoform Enters Exclusive Partnership with CBC to Bring Best-In-Class Nanomedicine Technology to Japan | CI |
Presentation Operator MessageOperator (Operator)Welcome to the Nanoform Q1 report 2023. ...
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe
Nanoform Finland Oyj is a Finland-based company that operates in the global pharmaceutical industry. The Company is an early-stage growth Company that develops various nanoforming technologies for application in the field of nanomedicine. Nanoform Finland Oyjâs business is to offer expert services in nanotechnology as well as drug particle engineering for global pharma and biotech industry. Nanoform Finland Oyj is the Parent Company of the Nanoform Group, and it has one subsidiary - Nanoform USA Inc. The Group production, research and development functions operate in Finland. The Groupâs strategy is to sell nanotechnological services widely to minimize the dependence from single customers or projects.
Calendar
2024-05-20
- Global DDF Summit
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
2.155
EUR
Average target price
4.4
EUR
Spread / Average Target
+104.18%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +35.96% | 197M | |
| +1.51% | 42.75B | |
| +49.22% | 41.61B | |
| +8.57% | 41.34B | |
| -12.36% | 26.59B | |
| +8.92% | 25.49B | |
| -25.13% | 18.12B | |
| +29.17% | 12.24B | |
| -3.12% | 11.76B | |
| +6.35% | 11B |
- Stock Market
- Equities
- NANOFH Stock
- News Nanoform Finland Oyj
- Transcript : Nanoform Finland Oyj, Q1 2023 Earnings Call, May 25, 2023
